Laila Formulations Private Limited
About Laila Formulations Private Limited
Data last updated:
Laila Formulations Private Limited is a private limited company based in Vijayawada, Andhra Pradesh, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 11 December 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2007PTC056627.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gokaraju Rathi Devi and Ganga Raju Gokaraju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 40 – 15 – 14 Brindavan Colony Labbipet, Vijayawada, Andhra Pradesh, India – 520010.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.8 Lakh. For the same year it recorded a net profit of ₹1.35 Lakh (net margin 74.8%) and EBITDA of ₹1.8 Lakh (EBITDA margin 100%). Revenue has declined at a compounded annual rate (CAGR) of 30% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address40 – 15 – 14 Brindavan Colony Labbipet, Vijayawada, Andhra Pradesh, India – 520010
- IndustryChemicals and Materials, Specialty Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Laila Formulations Private Limited FY 2025 filings available
Laila Formulations Private Limited reported revenue of ₹1.8 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR) of Laila Formulations Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 30% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Laila Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.8 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.35 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Laila Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 100% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 74.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Laila Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Laila Formulations Private Limited
Laila Formulations Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Formulations, Specialty Chemicals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hericure Healthcare Private Limited | ₹1.85 Lakh (FY 2025) | •••• | •••• | 1654.0% | •••• | Pune, Maharashtra, India |
| Kokad Pharmaceutical Laboratories Limited | ₹1.83 Lakh (FY 2025) | •••• | •••• | 53.0% | •••• | Kottayam, Kerala, India |
| Spiro Healthcare Private Limited | ₹1.82 Lakh (FY 2019) | •••• | •••• | -100.0% | •••• | Mumbai, Maharashtra, India |
| Marklabs Hygiene Private Limited | ₹1.82 Lakh (FY 2022) | •••• | •••• | 25.0% | •••• | New Delhi, Delhi, India |
| KLL Healthcare Private Limited | ₹1.81 Lakh (FY 2025) | •••• | •••• | 62.0% | •••• | Palghar, Maharashtra, India |
| Laila Formulations Private Limited this company | ₹1.8 Lakh (FY 2025) | •••• | •••• | •••• | Vijayawada, Andhra Pradesh, India | |
| Divye Life Sciences Private Limited | ₹1.79 Lakh (FY 2025) | •••• | •••• | -37.0% | •••• | Noida, Uttar Pradesh, India |
| Cyklo Pharma Chem Pvt Ltd | ₹1.79 Lakh (FY 2024) | •••• | •••• | -67.0% | •••• | Maharastra, Maharashtra, India |
| Ken Biotec Private Limited | ₹1.79 Lakh (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Hemline Flavours Private Limited | ₹1.79 Lakh (FY 2025) | •••• | •••• | -50.0% | •••• | Mumbai, Maharashtra, India |
| Schering-Plough (India) Private Limited | ₹1.78 Lakh (FY 2023) | •••• | •••• | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Laila Formulations by revenue in the Chemicals industry (Formulations, Specialty Chemicals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Laila Formulations Private Limited
Auditor information for Laila Formulations Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Laila Formulations Private Limited
Laila Formulations has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gokaraju Rathi Devi Also directs: Laila Aquatech Limited, Laila Chemicals Private Limited, Laila Tablets Private Limited and 5 more | Director | 11 Aug 2014 | 12 Years 2 Months | Current |
| Ganga Raju Gokaraju Also directs: Laila Aquatech Limited, Icurry Foods Private Limited, Nizam Deccan Sugars Limited and 5 more | Director | 11 Dec 2007 | 18 Years 10 Months | Current |
Ownership and Shareholding of Laila Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Laila Formulations Private Limited
Laila Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Laila Formulations Private Limited
Employment history and EPFO contributions of people linked to Laila Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Laila Formulations Private Limited
Laila Formulations Private Limited has 3 board changes on record since 2007: 2 appointments and 1 cessation. The latest: Gokaraju Rama Raju ceased to be Director on 11 Aug 2014.
Credit Ratings, Litigation & Regulatory Alerts for Laila Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Laila Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Laila Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Laila Formulations Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Laila Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Laila Formulations Private Limited
Laila Formulations is an active private limited company based in Vijayawada, Andhra Pradesh, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 11 December 2007 (19+ years old) and is registered under CIN U24232AP2007PTC056627.
Laila Formulations reported revenue of ₹1.8 Lakh for FY 2025.
Laila Formulations has 2 current directors:
- Gokaraju Rathi Devi - Director
- Ganga Raju Gokaraju - Director
Laila Formulations reported a net profit of ₹1.35 Lakh (net margin 74.8%) and EBITDA of ₹1.8 Lakh (EBITDA margin 100%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Laila Formulations is -30% over five years. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Laila Formulations is U24232AP2007PTC056627. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Laila Formulations was incorporated on 11 December 2007, making it 19+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Laila Formulations by revenue are Hericure Healthcare Private Limited, Kokad Pharmaceutical Laboratories Limited, Spiro Healthcare Private Limited, Marklabs Hygiene Private Limited, KLL Healthcare Private Limited and 5 more, all in the Chemicals industry (Formulations, Specialty Chemicals).
Gokaraju Rama Raju ceased to be Director on 11 Aug 2014. Gokaraju Rathi Devi was appointed as Director on 11 Aug 2014. Ganga Raju Gokaraju was appointed as Director on 11 Dec 2007.
The registered office of Laila Formulations is at 40 – 15 – 14 Brindavan Colony Labbipet, Vijayawada, Andhra Pradesh, India – 520010.
Laila Formulations has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.